The complex link between immunization against childhood diseases and allergy

Expert Review of Vaccines

Volumn 6, Issue 4, 2007, Pages 635-643

  Kalaboka, Sofia ^a,b,c,d   Annesi Maesano, Isabella ^b,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d IKY State Scholarships Foundation   (Greece)

Author keywords

Additives; Allergy; Asthma; Atopy; Egg; Gelatine; Hypersensitivity; Immunization; Influenza; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; CHICKENPOX VACCINE; CPG OLIGODEOXYNUCLEOTIDE; DENDRITIC CELL VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGITIS VACCINE; POLIOMYELITIS VACCINE; THIOMERSAL; TOLL LIKE RECEPTOR 1; VACCINE;

ABSCESS; ALLERGY; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTHUS PHENOMENON; ASTHMA; CHICKENPOX; CHILDHOOD DISEASE; CLINICAL TRIAL; DELAYED HYPERSENSITIVITY; DIPHTHERIA; DRUG FORMULATION; ECZEMA; GENE THERAPY; HUMAN; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; INFECTION; INFLAMMATION; INFLUENZA; INJECTION SITE REACTION; MEASLES; MEDICAL LITERATURE; MENINGITIS; MUMPS; PERTUSSIS; POLIOMYELITIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RASH; REVIEW; RUBELLA; SERUM SICKNESS; SKIN TEST; TETANUS; TUBERCULOSIS; VASCULITIS;

ASTHMA; CHILD; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNIZATION; INFLUENZA VACCINES; VACCINES;

EID: 34548036017     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.6.4.635     Document Type: Review

References (72)

1. American Academy of Pediatrics. Vaccine safety and contraindications. In: Red Book: Report of the Committee on Infectious Diseases, 25th Edition, Pickering LK (Ed). 30-39 (2000).
2. Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 45, 1-35 (1996).
3. World Health Organization, Department of Vaccines and Biologicals. Supplementary information on vaccine safety. Part 2: Background rates of adverse events following immunization. WHO/V&B/0036 (2000).
4. Bidat E, Rance F, Gaudelus J. Vaccination in children with egg allergy. Arch. Pediatr. 10, 251-253 (2003).
5. Ponvert C. Vaccinations et allergie. Rev. Fr. Allergol. Immunol. Clin. 47, 9-15 (2007).
6. Ponvert C, Scheinmann P. Vaccine allergy and pseudo-allergy. Eur. J. Dermatol. 13, 10-15 (2003). •• Comprehensive review regarding allergic and pseudoallergic reactions to vaccines.
7. Martignon G, Oryszczyn PM, Annesi-Maesano I. Does childhood immunization against infectious diseases protect from the development of atopic disease? Pediatr. Allergy Immunol. 16, 193-200 (2005). •• First study taking into account all vaccines and their type (live, inactivated and attenuated) with the lot number of every vaccine.
8. Kennedy CR, Byers SV, Marchalonis JJ. Measles virus infection and vaccination: potential role in chronic illness and associated adverse events. Crit. Rev. Immunol. 24, 129-156 (2004).
9. Kelso MJ, Mootrey TG, Tsai FT. Anaphylaxis from yellow fever vaccine. J. Allergy Clin. Immunol. 103, 698-701 (1999).
10. Eigenmann PA. Allergie à l'oeuf: state of the art. Rev. Fr. Allergol. Immunol. Clin. 43, 450-454 (2003).
11. James MJ, Burks WA, Roberson PK, Sampson HA. Safe administration of the measles vaccine to children allergic to eggs. N. Engl. J. Med. 332, 1262-1266 (1995).
12. Pool V, Braun MM, Kelso MJ et al. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. Pediatrics 110, E71 (2002).
13. Kuno-Sakai H, Kimura M. Removal of gelatin from live vaccines and DTaP - an ultimate solution for vaccine-related gelatin allergy. Biologicals 31, 245-249 (2003).
14. Nakayama T, Kumagai T. Gelatin allergy. Pediatrics 113, 170-171; author reply 1 (2004).
15. Kumagai T, Yamanaka T, Wataya Y et al. A strong association between HLA-DR9 and gelatin allergy in the Japanese population. Vaccine 19, 3273-3276 (2001).
16. Kelso MJ, Jones TR, Yunginger WJ. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin. J. Allergy Clin. Immunol. 91, 867-872 (1993).
17. Levy E. French economic evaluations of influenza and influenza vaccination. Pharmacoeconomics 9(Suppl. 3), 62-66 (1996).
18. Sugai K, Shiga A, Okada K et al. Dermal testing of vaccines for children at high risk of allergies. Vaccine 25(17), 3454-3463 (2007).
19. Parker KS, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 114, 793-804 (2004).
20. Heron J, Golding J. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114, 577-583 (2004).
21. Gold M, Goodwin H, Botham S et al. Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service. Arch. Dis. Child. 83, 128-131 (2000).
22. Ponvert C, Scheinmann P, Karila C et al. L'allergie aux vaccins associés chez l'enfant: une étude de 30 cas fondée sur les tests cutanées à lecture immédiate, semiretardée et retardée, sur les dosages des anticorps spécifiques et sur les injections de rappel. Rev. Fr. Allergol. Immunol. Clin. 41, 701-711 (2001).
23. Fauquert JL, Tridon A, Labbé A et al. Réaction anaphylactoide post-BCG: le rôle du dextran? Rev. Fr. Allergol. Immunol. Clin. 41, 412-414 (2001).
24. Holt GP, Rudin A, Macaubas C et al. Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children. J. Allergy Clin. Immunol. 105, 1117-1122 (2000).
25. Lavi S, Zimmerman B, Koren G et al. Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children. JAMA 263, 269-271 (1990).
26. Andrews MR, Kempe EA, Sinn KK et al. Vaccinating children with a history of serious reactions after vaccination or of egg allergy. Med. J. Aust. 168, 491-494 (1998).
27. Khakoo AG, Lack G. Guidelines for measles vaccination in egg-allergic children. Clin. Exp. Allergy 30, 288-293 (2000). • Useful guidelines for measles vaccination in egg-allergic children.
28. Patja A, Makinen-Kiljunen S, Davidkin I et al. Allergic reactions to measles-mumps-rubella vaccination. Pediatrics 107, E27 (2001).
29. Chiu JW, Kuo LM, Chen CL et al. Evaluation of clinical and immunological effects of inactivated influenza vaccine in children with asthma. Pediatr. Allergy Immunol. 14, 429-436 (2003).
30. Kramarz P, DeStefano F, Gargiullo MP et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team. Arch. Fam. Med. 9, 617-623 (2000).
31. Sener M, Gursel G, Turktas H. Effects of inactivated influenza virus vaccination on bronchial reactivity symptom scores and peak expiratory flow variability in patients with asthma. J. Asthma 36, 165-169 (1999).
32. American Lung Association of Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N. Engl. J. Med. 345, 1529-1536 (2001).
33. Chin W, Kuo M, Tsao C et al. Evaluation of clinical and immunological effects of inactivated influenza vaccine in children with asthma. Pediatr. Allergy Immunol. 14, 429-436 (2003).
34. Gruber C, Niggemann B. A practical approach to immunization in atopic children. Allergy 57, 472-479 (2002). •• Interesting practical approach to the immunization of allergic children.
35. Brouard J, Freymuth F, Toutain F et al. Exacerbations de l'asthme et infection virale associée à celle du Chlamydia pneumoniae et du Mycoplasma pneumoniae: épidémiologie comparative entre nourrissons et enfants âgés de plus de deux ans. Rev. Fr. Allergol. Immunol. Clin. 41, 389-395 (2001).
36. Christy C, Aligne AC, Auinger P, Pulcino T, Weitzman M. Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch. Dis. Child. 89, 734-735 (2004).
37. Sugaya N, Nerome K, Ishida M, Matsumoto M, Mitamura K, Nirasawa M. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. JAMA 272, 1122-1126 (1994).
38. Thumerelle C, Deschildre A, Bouquillon C et al. Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region (France). Pediatr. Pulmonol. 35, 75-82 (2003).
39. Smits JA, Hak E, Stalman AW et al. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol. Infect. 128, 205-211 (2002).
40. DeStefano F, Gu D, Kramarz P et al. Childhood vaccinations and risk of asthma. Pediatr. Infect. Dis J. 21, 498-504 (2002). •• Cohort study of 167,240 children enrolled in four large health-maintenance organizations from 1991 to 1997, evaluating the association between childhood vaccinations (ascertained through computerized immunization tracking systems) and risk of asthma (identified through computerized data on medical care encounters and medications).
41. Maher EJ, Mullooly PJ, Drew L, DeStefano F. Infant vaccinations and childhood asthma among full-term infants. Pharmacoepidemiol. Drug Saf. 13, 1-9 (2004).
42. Bueving JH, Bernsen MR, Jongste d CJ et al. Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am. J. Respir. Crit. Care Med. 169, 488-493 (2004).
43. Cates JC, Jefferson OT, Bara AI, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst. Rev. CD000364 (2004). • Cochrane database review of randomized trials of influenza vaccination in children and adults with asthma (until February 2003).
44. Williams, J, Goodwin P. Influenza immunisation in children: good for everyone or reserve for the chosen few? Paediatr. Respir. Rev. 5, 85-89 (2004).
45. Glezen PW. Asthma, influenza, and vaccination. J. Allergy Clin. Immunol. 118, 1199-206; quiz 207-208 (2006).
46. Martin LB, Nelson RM, Hershey JN, Engler RJ. Adverse reactions to vaccines. Clin. Rev. Allergy Immunol. 24, 263-276 (2003).
47. Gruber C, Illi S, Lau S et al. Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics 111, E282-E288 (2003).
48. Wouden vd CJ, Bernsen MR. Childhood immunization and atopic disease. Pediatr. Allergy Immunol. 17, 234; author reply 5 (2006).
49. Alm SJ, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 353, 1485-1488 (1999). • Cross-sectional study of two anthroposophic schools, relating vaccines with atopy in children having this particular lifestyle.
50. Kemp T, Pearce N, Fitzharris P et al. Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology 8, 678-680 (1997).
51. Hurwitz LE, Morgenstern H. Effects of diphtheria-tetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J. Manipulative Physiol. Ther. 23, 81-90 (2000).
52. Olesen BA, Juul S, Thestrup-Pedersen K. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection. Acta Derm. Venereol. 83, 445-450 (2003).
53. Henderson J, North K, Griffiths M et al. Pertussis vaccination and wheezing illnesses in young children: prospective cohort study. The Longitudinal Study of Pregnancy and Childhood Team. Br. Med. J. 318, 1173-1176 (1999).
54. Strannegard LI, Larsson OL, Wennergren G, Strannegård O. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 53, 249-254 (1998).
55. Yilmaz M, Bingol G, Altinta D, Kendirli SG. Correlation between atopic diseases and tuberculin responses. Allergy 55, 664-667 (2000).
56. Mohrenschlager M, Haberl MV, Krämer U, Behrendt H, Ring J. Early BCG and pertussis vaccination and atopic diseases in 5- to 7-year-old preschool children from Augsburg, Germany: results from the MIRIAM study. Pediatr. Allergy Immunol. 18, 5-9 (2007).
57. Maitra A, Sherriff A, Griffiths M et al. Pertussis vaccination in infancy and asthma or allergy in later childhood: birth cohort study. Br. Med. J. 328, 925-926 (2004).
58. Nilsson L, Kjellman IN, Bjorksten B. Allergic disease at the age of 7 years after pertussis vaccination in infancy: results from the follow-up of a randomized controlled trial of 3 vaccines. Arch. Pediatr. Adolesc. Med. 157, 1184-1189 (2003).
59. Annus T, Montgomery MS, Riikjarv AM et al. Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and the age at BCG vaccination. Allergy 59, 1068-1073 (2004).
60. Bager P, Rostgaard K, Nielsen MN et al. Age at bacille Calmette-Guerin vaccination and risk of allergy and asthma. Clin. Exp. Allergy 33, 1512-1517 (2003).
61. Gruber C, Kulig M, Bergmann R et al. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early bacille Calmette-Guerin- vaccinated and nonvaccinated children. Pediatrics 107, E36 (2001).
62. Marks BG, Ng K, Zhou J et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J. Allergy Clin. Immunol. 111, 541-549 (2003).
63. Koppen S, Groot d R, Neijens HJ, Nagelkerke N, van Eden W, Rumke HC. No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine 22, 3375-3385 (2004). •• Meta-analysis with articles from 1966 to 2003 relating vaccination and allergy.
64. McKeever MT, Lewis AS, Smith C, Hubbard R. Vaccination and allergic disease: a birth cohort study. Am. J. Public Health 94, 985-989 (2004). • Birth cohort study of approximately 29,000 children from a large, longitudinal primary care data set, relating vaccination with the incidence of physician-diagnosed asthma and eczema.
65. Pershagen G. Can immunization affect the development of allergy? Pediatr. Allergy Immunol. 11(Suppl. 13), 26-28 (2000).
66. Anderson RH, Poloniecki DJ, Strachan PD et al. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am. J. Public Health 91, 1126-1129 (2001). •• International study relating national immunization rates in 56 countries to the prevalence of allergic manifestations in the corresponding regions.
67. Jedrychowski W, Maugeri U, Jedrychowska-Bianchi I. Prospective epidemiologic study on respiratory diseases in children and immunization against measles. Int. J. Occup. Med. Environ. Health 17, 255-261 (2004).
68. Aaby P, Shaheen OS, Heyes BC et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin. Exp. Allergy 30, 644-650 (2000).
69. Gruber C, Nilsson L, Bjorksten B. Do early childhood immunizations influence the development of atopy and do they cause allergic reactions? Pediatr. Allergy Immunol. 12, 296-311 (2001).
70. Gruber C, Meinlschmidt G, Bergmann R, Wahn U, Stark K. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds. Pediatr. Allergy Immunol. 13, 177-181 (2002).
71. Bernsen MR, de Jongste CJ, van der Wouden CJ. Lower risk of atopic disorders in whole cell pertussis-vaccinated children. Eur. Respir. J. 22, 962-924 (2003).
72. da Cunha SS, Cruz AA, Dourado I, Barreto ML, Ferreira LD, Rodrigues LC. Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG. Allergy 59, 857-862 (2004).